Agenus | AGEN - Ebit





Ebit Alterar Data
AbbVie USD 6.88B 156M 2026-09
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Celldex Therapeutics USD -80.62M 3.81M 2026-06
CSL USD 2.64B 116M 2025-12
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 6.47B 1B 2026-09
Jiangsu Hengrui CNY 2.85B 1.17B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -65.25M 33.36M 2026-06
Merck EUR 1.1B 51M 2026-06
Merck USD 7.33B 6.49B 2026-09
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Novartis USD 5.14B 411M 2026-09
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.85B 5.03B 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 18.02M 5.94M 2026-09